This page lists the SEC filings reported by New Enterprise Associates 14, L.P..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2018-02-12 | New Enterprise Associates 14, L.P. | MongoDB, Inc. | 3,078,185 | 25.2% | EDGAR |
| SC 13D/A | 2018-02-01 | New Enterprise Associates 14, L.P. | SYNLOGIC, INC. | 4,228,940 | 19.7% | EDGAR |
| SC 13G/A | 2018-01-29 | New Enterprise Associates 14, L.P. | Adaptimmune Therapeutics PLC | 72,138,996 | 12.8% | EDGAR |
| SC 13G | 2018-01-29 | New Enterprise Associates 14, L.P. | APPIAN CORP | 2,724,202 | 19.8% | EDGAR |
| SC 13G | 2018-01-29 | New Enterprise Associates 14, L.P. | MULESOFT, INC | 16,115,887 | 17.7% | EDGAR |
| SC 13D/A | 2017-09-07 | New Enterprise Associates 14, L.P. | SYNLOGIC, INC. | 3,818,940 | 23.5% | EDGAR |
| SC 13D | 2017-07-11 | New Enterprise Associates 14, L.P. | Mersana Therapeutics, Inc. | 8,140,138 | 36.0% | EDGAR |
| SC 13D/A | 2017-05-16 | New Enterprise Associates 14, L.P. | Mirna Therapeutics, Inc. | 2,971,517 | 14.2% | EDGAR |
| SC 13G/A | 2017-02-14 | New Enterprise Associates 14, L.P. | Adaptimmune Therapeutics PLC | 59,269,000 | 14.0% | EDGAR |
| SC 13G/A | 2017-02-06 | New Enterprise Associates 14, L.P. | Cerecor Inc. | - | - | EDGAR |
| SC 13D/A | 2016-12-08 | New Enterprise Associates 14, L.P. | Tracon Pharmaceuticals, Inc. | 2,758,039 | 17.6% | EDGAR |
| SC 13D/A | 2016-11-21 | New Enterprise Associates 14, L.P. | Loxo Oncology, Inc. | - | - | EDGAR |
| SC 13D/A | 2016-09-13 | New Enterprise Associates 14, L.P. | Loxo Oncology, Inc. | 1,289,420 | 6.0% | EDGAR |
| SC 13G | 2016-02-10 | New Enterprise Associates 14, L.P. | Adaptimmune Therapeutics PLC | 59,269,000 | 14.0% | EDGAR |
| SC 13G/A | 2016-02-01 | New Enterprise Associates 14, L.P. | NEVRO CORP | - | - | EDGAR |
| SC 13G | 2016-02-01 | New Enterprise Associates 14, L.P. | Cerecor Inc. | 594,245 | 6.9% | EDGAR |
| SC 13D | 2015-10-14 | New Enterprise Associates 14, L.P. | Mirna Therapeutics, Inc. | 2,971,517 | 14.8% | EDGAR |
| SC 13D | 2015-03-24 | New Enterprise Associates 14, L.P. | CHAMPIONS ONCOLOGY, INC. | 29,062,500 | 25.4% | EDGAR |
| SC 13D | 2015-02-11 | New Enterprise Associates 14, L.P. | Tracon Pharmaceuticals, Inc. | 1,888,474 | 15.6% | EDGAR |
| SC 13G | 2015-02-09 | New Enterprise Associates 14, L.P. | NEVRO CORP | 1,367,649 | 5.5% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.